catalyst for nadaq rise?

Unilife Corporation Analyst Notes

On March 13, 2014, Unilife Corporation (Unilife) announced that it has entered into a $60 million debt financing agreement with an affiliate of OrbiMed. According to the Company, $40 million was funded to Unilife at the closing of the deal, and two additional tranches of $10 million each will be provided to the Company in December 2014 and June 2015, provided the Company is in compliance with the terms of the agreement. Additionally, Unilife stated that it will make interest-only payments to OrbiMed currently calculated at a rate of 10.25% per annum, with the principal to be repaid by March 12, 2020, within the six-year term of the agreement. Unilife Chairman and CEO Mr. Alan Shortall, stated, "This $60 million commitment provides us with the necessary capital to drive business growth as we bring several large contracts with existing customers through to commercial rollout." The full analyst notes on Unilife Corporation are available to download free of charge at:

http://www.AnalystsReview.com/03192014/UNIS/report.pdf

http://online.wsj.com/article/PR-CO-20140319-906003.html